Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dukevn
    Member
    • Apr 2009
    • 50

    #1

    BWA, BOWTIE: what parameters for different analysis (ChIP, RNA, miRNA etc)

    Hi all,

    I am still learning towards next generation sequencing and still do not have much experience on the field, so hopefully people are willing to share their experience. I wonder what parameters do people use (with BWA and/or BOWTIE) for different analysis such as ChIP-SEQ, RNA-SEQ, miRNA-SEQ etc... I read somewhere that mapping of data from RNA samples (RNAseq) presents different genome mapping challenges than those from DNA, that means there should be different parameters / options for different mapping analysis. Anybody has any advice?

    Thanks,

    D.
  • mrawlins
    Member
    • Apr 2010
    • 63

    #2
    I asked a similar question (limited to RNA-Seq) on the Q/A site. The link to that and the answers is


    I found that using Bowtie for RNA-Seq we benefited from a larger error tolerance in the tail (-e 980) than we would have wanted for DNA. Mostly that's because we weren't particularly interested in SNP calling in those samples.

    Comment

    • dukevn
      Member
      • Apr 2009
      • 50

      #3
      Originally posted by mrawlins View Post
      I asked a similar question (limited to RNA-Seq) on the Q/A site. The link to that and the answers is


      I found that using Bowtie for RNA-Seq we benefited from a larger error tolerance in the tail (-e 980) than we would have wanted for DNA. Mostly that's because we weren't particularly interested in SNP calling in those samples.
      Thanks for the link, mrawlins. Even it does not fully answer my question (parameters for ChIP vs RNA vs miRNA etc), and that it is for SOLID only, but it does give me some infos about parameter that others are using.

      Thanks,

      D.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...